Commission Implementing Regulation (EU) 2022/1255 of 19 July 2022 designating antimicrobials or groups of antimicrobials reserved for treatment of certain infections in humans, in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act included in a Joint Committee Decision (JCD); entry into force of the Decision is pending Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XIII Medicinal Products
Legal documents
Commission Implementing Regulation (EU) 2022/1255 of 19 July 2022 designating antimicrobials or groups of antimicrobials reserved for treatment of certain infections in humans, in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council
Durchführungsverordnung (EU) 2022/1255 der Kommission vom 19. Juli 2022 zur Bestimmung von antimikrobiellen Wirkstoffen oder von Gruppen antimikrobieller Wirkstoffe, die gemäß der Verordnung (EU) 2019/6 des Europäischen Parlaments und des Rates der Behandlung bestimmter Infektionen beim Menschen vorbehalten bleiben müssen
History
04.02.2023
Adopted JCD confirmed entry into force date
09.02.2023
Compliance date in the EEA
03.02.2023
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
07.12.2022
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
19.07.2022
Adoption date in the EU
09.02.2023
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.